Skip to content
healthcare.dev

CELISTAR MICRONEEDLING INFUSION

NDC 87765-001, HYALURONATE SODIUM, liquid, from Guangdong Outeli Biotechnology Co., Ltd..

Product NDC
87765-001
Status
Listed
Labeler
Guangdong Outeli Biotechnology Co., Ltd.
Dosage form
LIQUID
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M016
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87765-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYALURONATE SODIUM3.5 g/100mL
  • HYDROLYSED MARINE COLLAGEN (ENZYMATIC2.5 g/100mL
  • 2000 MW)
Package NDCNDC-11Package
87765-001-018776500010120 mL in 1 BOX (87765-001-01)
87765-001-028776500010210 mL in 1 BOX (87765-001-02)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 87765-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87765-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87765-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.